Connection

Jochen Schneider to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Jochen Schneider has written about Antibodies, Monoclonal.
Jochen Schneider
Connection Strength
0.014
Antibodies, Monoclonal
  1. Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany. Infection. 2021 Dec; 49(6):1313-1318.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.